Vaxer Pharma Limited - Due diligence report

A 360° intelligence report on Vaxer Pharma Limited: trust score, financial health, credit view, compliance, directors, growth and distress s…

2011-08-30 Urban Estate, Haryana Active Unlisted Active Compliant
Share
VP Vaxer Pharma Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Vaxer Pharma Limited — 360° Intelligence Report

Generated from MCA filings & public records
92/100
Trust Score
Low Risk

Vaxer Pharma Limited is assessed as Low Risk with a Trust Score of 92/100. Vaxer Pharma Limited is an active public limited indian non-government company incorporated in 2011, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 16 Jul 2026 from the latest processed filings. Vaxer Pharma Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
92/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
88/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Moderate gearing (D/E 1.42).
  • Profitable - internal accruals available.

Charges position: 1 open (15.00 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Yes Bank Limited1 48.0 cr
Compliance Score: 88/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
BODH RAJ SIKRI 01234567 Director 01/04/2018 6 yrs Approved
POCHIRAJU HANUMATH SUBBA RAO 01234567 Director 01/04/2018 6 yrs Approved
ANSHUL SIKRI 01234567 Director 01/04/2018 6 yrs Approved
SUMAN MALHOTRA 01234567 Director 01/04/2018 6 yrs Approved
AASTHA DEWAN 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
1
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Abs Mercantiles Private Limited Associate Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Operating for 14+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
1 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence90/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment72/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 15.00 cr already registered.
  • Compliance record supports lending.
Investor view82/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 14 events
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
28 Dec 2022
Charge created
Yes Bank Limited - 15.00 cr
30 Nov 2021
Director ceased
SUMAN MALHOTRA
Director ceased
AASTHA DEWAN
27 Mar 2021
Director appointed
SUMAN MALHOTRA (Director)
Director appointed
AASTHA DEWAN (Director)
30 Sep 2014
Director ceased
BODH RAJ SIKRI
16 Jan 2014
Director appointed
BODH RAJ SIKRI (Director)
Director ceased
ROHIT REDDY PENAKA
Director ceased
GELLI VENKATA SESHAIAH
30 Aug 2011
Incorporated
Registered with Roc Delhi
Director appointed
POCHIRAJU HANUMATH SUBBA RAO (Director)
Director appointed
ANSHUL SIKRI (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Ask Agencies And Investments Private Limited U51900MH1995PTC093732 Mumbai-400059, Maharashtra, India
Anand Shree Steels Private Limited U27100TG2010PTC067360 Hyderabad, Telangana, India
Orbit Motors U51909OR1996PTC041064 Rourkela, Orissa, India
Eminent Jewel Arcade Private Limited U51398KL2010PTC026078 Calicut, Kerala, India
Dhanalakshmi Autozone India Private Limited U50402TG2016PTC109520 Hyderabad, Telangana, India
Blue Wave It Solutions India Private Limited U72200TG2013PTC087402 Secunderabad, Telangana, India
Indraprastha Motors Private Limited U50404DL2017PTC312609 New Delhi, Delhi, India
Glassex (India) Pvt Ltd U26100MH1992PTC068445 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Vaxer Pharma Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Vaxer Pharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Vaxer Pharma Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 92/100, distress signals and MSME payment-delay disclosures - know whether Vaxer Pharma Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Vaxer Pharma Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Vaxer Pharma Limited an active company?

Vaxer Pharma Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).

Is Vaxer Pharma Limited financially healthy?

Vaxer Pharma Limited has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Vaxer Pharma Limited?

Its overall Trust Score is 92/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Vaxer Pharma Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 5 active director(s) are on record.

Does Vaxer Pharma Limited have loans or charges against its assets?

1 open charge(s) are registered against its assets.

Is Vaxer Pharma Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 88/100 (Low Risk).

Is it risky to lend to Vaxer Pharma Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.